|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
37,070,000 |
Market
Cap: |
2.35(B) |
Last
Volume: |
12,537,091 |
Avg
Vol: |
5,842,868 |
52
Week Range: |
$63.44 - $63.44 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pla Frederic |
COO |
|
2019-03-18 |
4 |
AS |
$75.12 |
$75,122 |
D/D |
(1,000) |
31,575 |
|
- |
|
Pla Frederic |
COO |
|
2019-03-18 |
4 |
OE |
$27.48 |
$27,480 |
D/D |
1,000 |
32,575 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-18 |
4 |
S |
$74.19 |
$8,125,968 |
I/I |
(109,533) |
8,586,759 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-15 |
4 |
S |
$74.50 |
$4,131,088 |
I/I |
(55,347) |
8,677,010 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-14 |
4 |
S |
$76.03 |
$4,978,787 |
I/I |
(65,094) |
8,722,615 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2019-03-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
333,479 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-13 |
4 |
S |
$75.40 |
$6,092,923 |
I/I |
(80,253) |
8,776,250 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-12 |
4 |
S |
$75.63 |
$5,610,248 |
I/I |
(74,180) |
8,842,376 |
|
- |
|
Cole G Bradley |
CFO |
|
2019-03-12 |
4 |
AS |
$74.98 |
$1,127,273 |
I/I |
(15,000) |
43,722 |
|
- |
|
Cole G Bradley |
CFO |
|
2019-03-12 |
4 |
OE |
$17.18 |
$315,700 |
I/I |
15,000 |
58,722 |
|
- |
|
Leber Laura |
Chief Communication Officer |
|
2019-03-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
275 |
13,420 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-11 |
4 |
S |
$74.03 |
$3,677,484 |
I/I |
(49,035) |
8,903,498 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2019-03-08 |
4 |
AS |
$73.18 |
$732,237 |
I/I |
(10,000) |
125,952 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-08 |
4 |
S |
$73.55 |
$1,669,519 |
I/I |
(22,700) |
8,943,901 |
|
- |
|
Vaughn James J |
Chief Commercial Officer |
|
2019-03-07 |
4 |
AS |
$72.95 |
$221,596 |
D/D |
(3,000) |
22,790 |
|
- |
|
Vaughn James J |
Chief Commercial Officer |
|
2019-03-07 |
4 |
OE |
$31.12 |
$93,360 |
D/D |
3,000 |
25,790 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-07 |
4 |
S |
$73.72 |
$147,445 |
I/I |
(2,000) |
8,962,604 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-05 |
4 |
S |
$77.04 |
$793,504 |
I/I |
(10,300) |
8,964,251 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-04 |
4 |
S |
$76.49 |
$2,127,249 |
I/I |
(27,811) |
8,972,737 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2019-03-04 |
4 |
AS |
$74.76 |
$569,202 |
I/I |
(7,500) |
335,479 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2019-03-04 |
4 |
OE |
$28.05 |
$210,375 |
I/I |
7,500 |
342,979 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-01 |
4 |
S |
$77.15 |
$6,120,387 |
I/I |
(79,276) |
8,995,651 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2019-03-01 |
4 |
AS |
$77.08 |
$1,930,424 |
I/I |
(25,000) |
335,479 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2019-03-01 |
4 |
OE |
$28.05 |
$701,250 |
I/I |
25,000 |
360,479 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-02-28 |
4 |
S |
$76.20 |
$45,719 |
I/I |
(600) |
9,060,972 |
|
- |
|
1769 Records found
|
|
Page 6 of 71 |
|
|